Compare EML & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EML | STIM |
|---|---|---|
| Founded | 1858 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.9M | 140.6M |
| IPO Year | 1995 | 2018 |
| Metric | EML | STIM |
|---|---|---|
| Price | $21.87 | $1.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 16.0K | ★ 2.5M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.98% | N/A |
| EPS Growth | ★ 185.40 | 57.25 |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $248,970,345.00 | $52,776,000.00 |
| Revenue This Year | $19.05 | $11.10 |
| Revenue Next Year | N/A | $11.92 |
| P/E Ratio | $199.09 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.61 | $0.80 |
| 52 Week High | $26.76 | $4.84 |
| Indicator | EML | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 60.97 | 43.84 |
| Support Level | $21.54 | $1.21 |
| Resistance Level | $22.80 | $1.75 |
| Average True Range (ATR) | 0.48 | 0.14 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 87.81 | 23.53 |
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.